Stephen J. Tulipano

Steve is the chief financial officer at Stoke Therapeutics. Prior to joining Stoke, Steve served as chief financial officer and Treasurer of Aldeyra Therapeutics, where he worked with the Aldeyra team to advance multiple product candidates in orphan and non-orphan diseases, led the company’s strategic financings, and completed a development and commercialization agreement with a major biopharmaceutical company, among other accomplishments. He also spent five years as chief financial officer and secretary of Javelin Pharmaceuticals, Inc., a pharmaceutical development company focused on pain relief that was acquired by Hospira, Inc. in 2010. Prior to that, he was director of corporate accounting at Biogen Inc., where he led an accounting team supporting external reporting, research and development, and manufacturing. In his early career, Steve worked as an auditor and accountant for several Massachusetts-based accounting firms and technology companies. He holds a B.S. in business administration and accounting from Salem State College and an MBA from the Sawyer School of Management at Suffolk University. He is a Certified Public Accountant (CPA).